Interventional Spine, Inc. Completes Sale to DePuy Synthes
Represented Interventional Spine, Inc. in its sale of substantially all of its assets to DePuy Synthes, a subsidiary of Johnson & Johnson (NYSE: JNJ), for an undisclosed price. Interventional Spine developed, manufactured and marketed implantable devices and related instrumentation for spinal surgery and will continue to provide transitional and development services to DePuy.
DePuy Synthes and Interventional Spine have a common goal—advancing spinal care for patients with debilitating degenerative disc disease and expanding access to this important technology globally,” said Ciro Römer, Company Group Chairman, DePuy Synthes.
